Clinical and mycological aspects of recurrent onychomycosis;Kliniczne i mikologiczne aspekty nawrotowej grzybicy paznokci

Mikologia Lekarska

Volumn 10, Issue 2, 2003, Pages 85-91

  Ratajczak Stefańska, Violetta ^a   Maleszka, Romuald ^a  

^a POMERANIAN MEDICAL UNIVERSITY   (Poland)

Author keywords

Amorolfine; Itraconazole; Pentoxifylline; Recurrent onychomycosis; Terbinafine

Indexed keywords

AMIDASE; AMOROLFINE; BETA GALACTOSIDASE; ITRACONAZOLE; N ACETYL BETA GLUCOSAMINIDASE; PENTOXIFYLLINE; TERBINAFINE; TRIACYLGLYCEROL LIPASE;

ADULT; AGED; ARTICLE; CLINICAL FEATURE; CONSERVATIVE TREATMENT; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DERMATOPHYTE; DRUG EFFICACY; ENZYME ACTIVITY; FINGER NAIL; FUNGUS CULTURE; HUMAN; MAJOR CLINICAL STUDY; MONOTHERAPY; MYCOLOGY; ONYCHOMYCOSIS; RECURRENT DISEASE; REMISSION; TREATMENT FAILURE; TREATMENT OUTCOME;

FUNGI;

EID: 0038587545     PISSN: 1232986X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Goodfield M.J.D., Evans E.G.V.: Combined treatment with surgery and short duration oral antifungal therapy in patients with limited dermatophyte toenail infection. J. Dermatol. Treat., 2000, 11, 259-262.
2. Odom R.B.: New therapies for onychomycosis. J. Am. Acad. Dermatol., 1996, 35, Suppl. 2, 26-30.
3. Maleszka R., Ratajczak V,: Obserwacje przebiegu leczenia grzybicy dermatofitowej paznokci u chorych z zaburzeniami kra̧żenia w kończynach dolnych. Post. Dermatol., 1999, 16, 289-294.
4. Pittrof F., Gerhards J., Erni W., Klecak G.: Loceryl nail lacquer realization of a new galenical approach to onychomycosis therapy. Clin. Exp. Dermatol., 1992, 17, Suppl. 1, 26-28.
5. Hay R.J.: (46) Treatment of dermatomycoses and onychomycoses - state of the art. Clin. Exp. Dermatol., 1992, 17, Suppl. 1, 2-5.
6. Polak A.: Amorolfine, Loceryl. Przegl. Dermatol., 1993, 80, 369-373.
7. Baran R., Feuilhade M., Datry A., Goettmann S., Pietrini P., Viguie C., Badillet G., Larnier C., Czernielewski J.: A randomised trial of amorolfine 5% solution nail lacquer combined with oral terbinafine compared with terbinafine alone in the treatment of dermatophytic toenail onychomycoses affecting the matrix region. Br. J. Dermatol., 2000, 142, 1177-1183.
8. Lecha M.: Amorolfine and itraconazole combination for severe toenail onychomycosis; results of an open randomized trial in Spain. Br. J. Dermatol. 2001, 145, Suppl. 60, 21-26.
9. Maleszka R., Ratka P., Lis M.: Evaluation of symptoms and mycotic tests in subjects with recurrent onychomycosis. Mikol. Lek., 1997, 4, 161-165.
10. Maleszka R.: Enzymatic activity of dermatophytes in various forms of onychomycosis. Mikol. Lek., 1999, 6, 77-83.
11. Maleszka R.: Leczenie różnych postaci grzybicy dermatofitowej paznokci. Mikol. Lek., 1999, 6, 157-164.
12. Nowicki R., Korting H. C.: Różnice w aktywności enzymatycznej dermatofitów. Mikol. Lek., 1995, 2, 209-213.
13. Plomer-Niezgoda E., Baran E., Cisło M., Hryncewicz-Gwózdz A., Walów B.: Badania aktywności enzymów hydrolitycznych wybranych grzybów pleśniowych i drożdżaków przy użyciu testu API ZYM. Mikol. Lek., 1998, 5, 157-164.
14. Davies R.R., Zaini F.: Enzymatic activities of Trichophyton rubrum and the chemotaxis of polymorphonuclear leukocytes. Sabouraudia, 1984, 22, 235-241.
15. Maleszka R., Adamski Z., Dworacki G.: Evaluation of lymphocytes subpopulations and natural killer cells in peripheral blood of patients treated for dermatophyte onychomycosis. Mycoses, 2001, 44, 487-492.